Genmab



Ebit Veränderung Datum
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
Almirall EUR 43.02M 3.42M 2025-06
Amarin USD -16755000 707K 2025-03
Amgen USD 3.6B 434M 2025-03
argenx SE USD 288.02M 149.08M 2025-06
AstraZeneca USD 3.51B 1.3B 2025-06
Bayer EUR 2.91B 2.06B 2025-03
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Demant DKK 2.34B 144M 2024-12
Exelixis USD 215.68M 28.82M 2025-07
Fresenius Medical Care EUR 431M 15M 2025-06
Galapagos EUR -57027000 101.68M 2025-06
Genmab DKK 1.33B 827.73M 2025-03
GlaxoSmithKline GBP 2.07B 462M 2025-06
GN Store Nord DKK 342M 259M 2025-03
GRIFOLS EUR 331.94M 57.97M 2025-06
Hikma Pharmaceutical USD 317M 85M 2024-12
Insmed USD -253876000 5.74M 2025-06
Lonza CHF 727M 193M 2024-12
Merck EUR 1.01B 138M 2025-03
Novartis USD -9190000000 13.87B 2025-06
Regeneron Pharmaceuticals USD 1.52B 608.6M 2025-06
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 1.51B 1.39B 2025-06
UCB EUR 502M 168M 2024-12


Genmab - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.